| Pharmacophore modeling, quantitative structure–activity relationship analysis, and in silico screening reveal potent glycogen synthase kinase-3β inhibitory activities for … MO Taha, Y Bustanji, MAS Al-Ghussein, M Mohammad, H Zalloum, ... Journal of medicinal chemistry 51 (7), 2062-2077, 2008 | 118 | 2008 |
| Combining ligand-based pharmacophore modeling, quantitative structure− activity relationship analysis and in silico screening for the discovery of new potent hormone sensitive … MO Taha, LA Dahabiyeh, Y Bustanji, H Zalloum, S Saleh Journal of medicinal chemistry 51 (20), 6478-6494, 2008 | 80 | 2008 |
| Discovery of new MurF inhibitors via pharmacophore modeling and QSAR analysis followed by in-silico screening MO Taha, N Atallah, AG Al-Bakri, C Paradis-Bleau, H Zalloum, KS Younis, ... Bioorganic & medicinal chemistry 16 (3), 1218-1235, 2008 | 74 | 2008 |
| Copper adsorption on chitosan-derived Schiff bases HM Zalloum, Z Al-Qodah, MS Mubarak Journal of Macromolecular Science, Part A 46 (1), 46-57, 2008 | 71 | 2008 |
| Pharmacophore and QSAR modeling of estrogen receptor β ligands and subsequent validation and in silico search for new hits MO Taha, M Tarairah, H Zalloum, G Abu-Sheikha Journal of Molecular Graphics and Modelling 28 (5), 383-400, 2010 | 48 | 2010 |
| Discovery of New Antifungal Leads via Pharmacophore Modeling and QSAR Analysis of Fungal N‐Myristoyl Transferase Inhibitors Followed by In Silico Screening MO Taha, AM Qandil, T Al‐Haraznah, RA Khalaf, H Zalloum, AG Al‐Bakri Chemical biology & drug design 78 (3), 391-407, 2011 | 29 | 2011 |
| Coffee bean polyphenols can form biocompatible template-free antioxidant nanoparticles with various sizes and distinct colors S Sunoqrot, E Al-Shalabi, AG Al-Bakri, H Zalloum, B Abu-Irmaileh, ... ACS omega 6 (4), 2767-2776, 2021 | 22 | 2021 |
| Nature-Inspired Polymerization of Quercetin to Produce Antioxidant Nanoparticles with Controlled Size and Skin Tone-Matching Colors HZ Suhair Sunoqrot, Eveen Al-Shalabi, Lina Hasan Ibrahim Molecules 24 (21), 2019 | 19 | 2019 |
| 1, 4-naphthoquinone is a potent inhibitor of IRAK1 kinases and the production of inflammatory cytokines in THP-1 differentiated macrophages IS Mahmoud, MM Hatmal, D Abuarqoub, E Esawi, H Zalloum, S Wehaibi, ... ACS omega 6 (39), 25299-25310, 2021 | 16 | 2021 |
| In Vitro modulation of pancreatic lipase and proliferation of obesity related colorectal cancer cell line panel by novel synthetic triazoloquinolones S Arabiyat, Y Al-Hiari, Y Bustanji, H Zalloum, V Kasabri Rev. Roum. Chim 61 (11-12), 871-879, 2016 | 15 | 2016 |
| Homology modeling of MCH1 receptor and validation by docking/scoring and protein-aligned CoMFA A Abu-Hammad, WA Zalloum, H Zalloum, G Abu-Sheikha, MO Taha European journal of medicinal chemistry 44 (6), 2583-2596, 2009 | 15 | 2009 |
| Antilipolytic and hypotriglyceridemic effects of dietary Salvia triloba Lf (Lamiaceae) in experimental rats S Arabiyat, A Al-Rabi'ee, H Zalloum, M Hudaib, M Mohammad, Y Bustanji Tropical Journal of Pharmaceutical Research 15 (4), 723-728, 2016 | 14 | 2016 |
| Combining ligand-based pharmacophore modeling, QSAR analysis and in-silico screening for the discovery of new potent hormone sensitive lipase inhibitors MO Taha, LA Dahabiyeh, Y Bustanji, H Zalloum, S Saleh J. Med. Chem 51, 6478-6494, 2008 | 14 | 2008 |
| Pancreatic Lipase Inhibitory Activity Of Selected Pharmaceutical Agents HZ Imad Hamdan, Violet Kasabri,Yusuf AlHiari, Dina El-Sabawi Acta Pharma, 2018 | 11* | 2018 |
| Ligand-based designing, in silico screening, and biological evaluation of new potent fructose-1, 6-bisphosphatase (FBPase) inhibitors RF Tayyem, HM Zalloum, MR Elmaghrabi, AM Yousef, MS Mubarak European journal of medicinal chemistry 56, 70-95, 2012 | 11 | 2012 |
| Synthesis, characterization, and anticancer evaluation of some new N1-(anthraquinon-2-yl) amidrazone derivatives K Sweidan, H Zalloum, DA Sabbah, G Idris, K Abudosh, MS Mubarak Canadian Journal of Chemistry 96 (12), 1123-1128, 2018 | 10 | 2018 |
| Discovery of new human epidermal growth factor receptor-2 (HER2) inhibitors for potential use as anticancer agents via ligand-based pharmacophore modeling H Zalloum, R Tayyem, Y Bustanji, M Zihlif, M Mohammad, TA Rjai, ... Journal of Molecular Graphics and Modelling 61, 61-84, 2015 | 9 | 2015 |
| Development of predictive in silico model for cyclosporine-and aureobasidin-based P-glycoprotein inhibitors employing receptor surface analysis HM Zalloum, MO Taha Journal of Molecular Graphics and Modelling 27 (4), 439-451, 2008 | 9 | 2008 |
| Antioxidant polymers: Metal chelating agents HM Zalloum, MS Mubarak Antioxidant Polymers: Synthesis, Properties, and Applications; Cirilo, G …, 2012 | 7 | 2012 |
| Fluoroquinolones as a potentially novel class of antidiabesity and antiproliferative compounds: synthesis and docking studies V Kasabri, S Arabiyat, Y Al-Hiari, H Zalloum, J Almaliti, A Telfah, ... Canadian Journal of Chemistry 98 (10), 635-645, 2020 | 6 | 2020 |
Yasser BustanjiProfessor of Biochemistry and Clinical Chemistry, University of Sharjah在 ju.edu.jo 的电子邮件经过验证
